Disclaimer : This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. The website does not sell/ purchase any medicine.
Description
Description
COMPOSITION: Each tablet contains Sofosbuvir 400 + Ledipasvir 90 mg
INDICATION: LEDIKAST is a fixed dose combination of hepatitis C virus nucleotide analog NSSB polymerase
inhibitor and NSSA inhibitor indicated for the treatment of:
- Indicated for the treatment of chronic HCV genotype 1 in adults
PACKING: 28 Tablets / Bottle
Download Product PDF Attachment